Keywords: osi, phgarma, pfizer, announce, phase, iv, macugen

OSI Phgarma and Pfizer announce Phase IV Macugen trial

Article | 03 July 2006

Print This

USA-based OSI Pharmaceuticals and world drugs giant Pfizer have announced the initiation of a Phase IV trial of Macugen (pegaptanib), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in